Bio Green Med Solution, Inc. (BGMS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.005x

Based on the latest financial reports, Bio Green Med Solution, Inc. (BGMS) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-33.00K) by net assets ($6.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bio Green Med Solution, Inc. (BGMS) balance sheet quality index to measure how much of total assets are equity-financed.

Bio Green Med Solution, Inc. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Bio Green Med Solution, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore BGMS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Bio Green Med Solution, Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio Green Med Solution, Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jaguar Animal Health Inc
NASDAQ:JAGX
-0.561x
Heavy Rare EARTHS Ltd
AU:HRE
-0.534x
Intercont (Cayman) Limited Ordinary shares
NASDAQ:NCT
N/A
Fairchild Gold Corp
V:FAIR
-0.117x
Mingteng International Corporation Inc. Ordinary Shares
NASDAQ:MTEN
-0.001x
Mobio Technologies Inc
V:MBO
0.549x
CARLSON INV. ZY 13
F:2HB
-0.001x
PVW Resources Ltd
AU:PVW
-1.696x

Annual Cash Flow Conversion Efficiency for Bio Green Med Solution, Inc. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Bio Green Med Solution, Inc. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see BGMS company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $6.84 Million $-4.77 Million -0.697x -118.97%
2024-12-31 $-2.17 Million $-7.99 Million 3.675x +113.85%
2023-12-31 $607.00K $-16.11 Million -26.544x -2504.15%
2022-12-31 $20.43 Million $-20.83 Million -1.019x -107.23%
2021-12-31 $37.69 Million $-18.54 Million -0.492x -106.19%
2020-12-31 $33.26 Million $-7.93 Million -0.239x +70.46%
2019-12-31 $11.70 Million $-9.45 Million -0.808x -84.07%
2018-12-31 $15.27 Million $-6.70 Million -0.439x -27.68%
2017-12-31 $21.77 Million $-7.48 Million -0.344x +51.33%
2016-12-31 $14.27 Million $-10.08 Million -0.706x +8.02%
2015-12-31 $18.84 Million $-14.46 Million -0.768x +10.97%
2014-12-31 $21.69 Million $-18.70 Million -0.862x -32.78%
2013-12-31 $28.02 Million $-18.20 Million -0.649x +45.97%
2012-12-31 $10.02 Million $-12.04 Million -1.202x -67.70%
2011-12-31 $19.50 Million $-13.98 Million -0.717x -11.35%
2010-12-31 $24.92 Million $-16.04 Million -0.644x +80.32%
2009-12-31 $4.64 Million $-15.19 Million -3.272x -125.82%
2008-12-31 $20.64 Million $-29.91 Million -1.449x -262.93%
2007-12-31 $57.97 Million $-23.14 Million -0.399x -6.70%
2006-12-31 $53.92 Million $-20.17 Million -0.374x +89.82%
2005-12-31 $4.12 Million $-15.14 Million -3.676x --

About Bio Green Med Solution, Inc.

NASDAQ:BGMS USA Biotechnology
Market Cap
$4.91 Million
Market Cap Rank
#28607 Global
#5789 in USA
Share Price
$0.89
Change (1 day)
-2.50%
52-Week Range
$0.60 - $5.95
All Time High
$5.95
About

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green M… Read more